| Literature DB >> 34198694 |
Marta d'Amora1, Vittoria Raffa2, Francesco De Angelis1, Francesco Tantussi1.
Abstract
Plasmonic nanoparticles are increasingly employed in several fields, thanks to their unique, promising properties. In particular, these particles exhibit a surface plasmon resonance combined with outstanding absorption and scattering properties. They are also easy to synthesize and functionalize, making them ideal for nanotechnology applications. However, the physicochemical properties of these nanoparticles can make them potentially toxic, even if their bulk metallic forms are almost inert. In this review, we aim to provide a more comprehensive understanding of the potential adverse effects of plasmonic nanoparticles in zebrafish (Danio rerio) during both development and adulthood, focusing our attention on the most common materials used, i.e., gold and silver.Entities:
Keywords: adulthood; development; gold; plasmonic nanoparticles; silver; toxicity; zebrafish
Mesh:
Year: 2021 PMID: 34198694 PMCID: PMC8232250 DOI: 10.3390/ijms22126372
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Action mechanisms of nanoparticles on zebrafish. (A) Exposure of eggs to nanoparticles dissolved in embryo medium by simple soaking or direct microinjection; (B) uptake and internalization of nanoparticles in zebrafish eggs by passive diffusion through the chorion pores (500–700 nm); (C) nanoparticles enter the circulatory system and accumulate in different tissues and organs; (D) effects of nanoparticles on zebrafish at different levels: organism (developmental changes), cells (ROS generation and apoptosis), and organs (neurotoxicity, respiratory toxicity, and hepatotoxicity). Abbreviation: NPs: nanoparticles; ROS: reactive oxygen species.
Figure 2Different factors influencing the gold nanoparticles’ toxicity: shape, size, functionalization, surface charge, and surface coatings. Abbreviations: shRNA: Short hairpin RNA; PEG: Poly (Ethylene Glycol); siRNA: Short interfering RNA.
Effects of gold nanoparticles with different sizes, shapes, and surface coatings in zebrafish.
| Life Stage | Shape | Size | Surface Coatings | Concentration and Time of Exposure | Mortality Value vs. Dosesor LC50 | Results | Ref. |
|---|---|---|---|---|---|---|---|
| Embryos | Sphere | 12 nm | Citrate | 0.025, 0.05, 0.10, 0.20, 0.40, 0.60, 0.80, 1.0, 1.2 nM, from cleavage-stage to 120 hpf | 31% at 1.2 nM | Effects stochastic dependent from concentration—low mortality—different malformations (fin fold abnormality, tail and spinal cord flexure and truncation, cardiac malformation, yolk sac edema, and acephaly). | [ |
| Embryos | Ellipse | 86 nm | Citrate | 0–78 µg/mL from 0.75/2.25 to 120 hpf | 3% at 78 µg/mL | Normal development—effects not concentration dependent—larger Au-NPs (86 nm) more biocompatible than smaller (12–35 nm). | [ |
| Embryos | Sphere | 0.8, 1.5, and 15 nm | TMAT | 0.016, 0.08, 0.4, 2, 10, 50 and 250 mg/L, from 2 to 120 hpf (5 days) |
100% at 250 ppm TMAT- Ag-NPs 55–60% at 250 ppm MES-Au-NPs <10% at 250 ppm MEE-Au-NPs <10% at 250 ppm MEEE-Au-NPs | [ | |
| Embryos | Sphere | 1.5 nm | TMAT | 0.016, 0.08, 0.4, 2, 10, 50 and 250 ppm, from 6 to 48 hpf |
100% at 10 ppm TMAT- Au-NPs 40% at 10 ppm MES—Au-NPs | [ | |
| Embryos | Sphere and oval | 15–35 nm | PVA | 10, 25, 50, 75, and 100 mg/mL, from 8-cell stage to 72 hpf | ≤3 at 100 mg/mL | No increase in mortality—no hatching delay—no defects in the development—no effects on the heartbeat rate—no perturbations in the touch response for all the tested concentrations. | [ |
| Embryos | Rod | 20 nm × 7 nm | CTAB | 50, 60, 72, 87, 104, 125, and 150 μg/L, from 6 to 96 hpf | L5096 h= 110.2 μg/L | Toxicity concentration dependent—at low doses (50 and 87 μg/L) no developmental perturbation—at high doses (125 and 150 μg/L) delay in the development (eye and brain) and different morphological abnormalities (tail deformities and pericardial edema, tail elongation, and body size)—no DNA damage. | [ |
| Embryos | Sphere | 79 | - | 5 mg/L, from 3 to 5 dpf | - | [ | |
| Embryos | Sphere | 33–346 nm | Folic acid | 0.325, 0.65, 0.97, 1.3, 1.62, 1.95, 2.27 and 2.6 ng/100 µL, from 2 hpf to 96 hpf | - | Toxicity concentration-dependent—decrease of survival rate—delay in the hatching rate—presence of different malformations (length of larvae and poor pigmentation). | [ |
| Embryos | Sphere | 25 and 40 nm | Citrate | Microinjection at one-cell stage with 1 nL (5 × 10−18 mole) | - | Normal development of somites—normal response to touch at 4 dpf—normal function of the cardiovascular system and other organs—normal expression of different genes ( | [ |
| Embryos | Sphere | 3, 10, 50, and 100 nm |
Bare
| 50, 5, 0.5 and 0.05 mg/L, from 4 to 120 hpf |
cAu3 negligible | No increase in mortality—no significant morphological defects—no differences in effects between unfunctionalized and functionalized NPs. | [ |
| Embryos | Sphere | 1.3 nm | TMAT | 0.08, 0.4, 2, 10 and 50 mg/L, from 4 hpf to 120 hpf | LC50120 hpf =30 mg/L | High mortality rate and high incidence of abnormalities—perturbations in the eye development, with grey and small eye—downregulation of genes involved in the eye formation and apoptosis processes—abnormal axon development. | [ |
| Embryos/adults | Sphere | 1.5 nm |
TMAT | 50 mg/L, embryos from 6 to 120 hpf, adult from 4 hpf to 122 days | 20% TMAT-Au-NPs | [ | |
| Embryos | Sphere | 1, 2.8, 3.1, 3.6, and 3.9 nm | MEEE | 2.3, 5, 10.7, 23.2, 50 µg/mL, from 6 hpf to 5 dpf | 88% at 50 µg/mL Au-NPs + 0.003 PS20Lily Zhao 100% at 23.2 µg/mL Au-NPs + 0.3 PS20 | Au-NPs and PS20 alone have low toxicity—mixtures of Au-NPs and PS20 presented increased toxicity. | [ |
| Embryos | Rod | 48 × 16 nm and 51 × 13 nm | CTAB | 1, 5, 10, 20 50 nM, from 4 to 120 hpf | - | Toxicity concentration dependent—up to middle dose, no perturbation in mortality and hatching rates and incidence of malformations—at the highest dose tested increased mortality, decreased hatching rate and presence of severe malformations (pericardial edema, yolk sac edema, tail flexure, and fin-fold abnormality). | [ |
| Embryos | Sphere | 46 nm | CTAB | 0–15.7 µM, from 4 to 80 hpf | LC5080 hpf | Mortality and hatching rates concentration dependent—order of induced mortality: Au nanospheres > nanopolyhedrons > nanorods—different malformations (several yolk sac edema, cardiac edema, bleeding, skeletal defects, lack of pigmentation, and tail/spinal cord flexure) with the highest percentages induced by polyhedrons. | [ |
| Embryos | Sphere Rod | 38.1 nm × 12 nm × 52 nm | 0.01, 0.025, 0.05 and 0.1 nM, from 2 to 72 hpf | - | [ | ||
| Embryos | Sphere | 1.2 nm | MPA | 0.08, 0.4, 2, 10 and 50 mg/L, from 6 to 120 hpf | <13% at 50 mg/mL | The ionic concentration of the EM influenced the toxicological profile—low mortality and percentage of malformations at highest ionic concentrations tested—normal motor activity. | [ |
| Embryos | Sphere | 1.16 and 11.6 nm | Citrate | 0, 1, 12.5, 25,50, 75, and 100 mg/L, from 4 to 96 hpf | LC50 above 100 mg/mL | Low mortality at the highest concentration of Au-NPs-CIT and Au-NPs-PVP tested—no hatching rate delay—no significant incidence of malformations. | [ |
| Embryos | Sphere | 5–50 nm | - | 100–300 mg/mL, from 4 to 96 hpf | 100% at 300 mg/mL | 100% mortality rate (concentration dependent) at the highest concentration tested—one abnormality (tail malformations). | [ |
| Adults | Sphere | 12 and 50 nm | Citrate | 0.04 and 0.1 mg/day/g fish body weight, 36 or 60 days | No mortality | No mortality—different impairment at the subcellular level, dependent on the exposure time and Au-NPs sizes and doses—mitochondrial perturbations in the muscle and the brain—perturbations in the expression of the genes associated with oxidative stress, apoptosis, and DNA repair. | [ |
| Adults | Sphere | 14 nm | Citrate | 0.25 and 0.8 mg/L, 20 days | - | Variations of brain and muscle AchE activity—DNA damage and alternations—variations in the expression of genes associated with oxidative stress, apoptosis, and DNA repair. | [ |
| Adults | Sphere | 10–20 nm and 40–50 nm | Citrate | 20 µg/g/day for 28 days | - | Histological alterations in ovarian tissue | [ |
| Adults | Sphere | <30 nm | - | 9.7, 19.4, 29.1, 38.8, 43.65, 48.5 and 58.2 mg/L for 96 h | LC5096 h = 41 mg/L | Toxicity concentration dependent—100% mortality at the highest concentration tested after 24 h—aggressive behavior after 12 h—no cytological changes—no genotoxicity. | [ |
| Adults | Sphere Rod | 16.5 nm | Mannose PEG | 2 µL for intraperitoneal injection (5 µ/g), 120 h | - | Very low toxicity. | [ |
Abbreviations: AchE: acetylcholine esterase; CIT: citrate; CTAB: cetyltrimethylammonium bromide; dpf: days post fertilization; EM: embryo medium; hpf: hours post fertilization; MEE: 2-(2-(2-mercaptoethoxy) ethoxy); MEEE: 2-(2-(2-mercaptoethoxy)ethoxy)ethanol; MES: mercaptoethane sulfonic acid; MPA: 3-mercaptopropionic acid; PAH/SS: polystyrene-sulfate and polyallamine hydrochloride; PEG: polyethylene glycol; PVA: polyvinyl alcohol; PVP: Polyvinylpyrrolidone; PS20: Polysorbate 20; PSS polystyrene-sulfate; TMAT: trimethylammonium ethanethiol; TPPMS: triphenylphosphine monosulfonate.
Figure 3Images of adult zebrafish: gills from (A) control sample and (B) treated with Ag-NPs, liver from control (C) control sample and (D) treated with Ag-NPs, and intestine (E) control sample and (F) treated with Ag-NPs. Reproduced with permissions from Devi, Aquatic Toxicology; published by Elsevier, 2015; Griffitt, Aquatic Toxicology; published by Elsevier, 2013; Osborne, ACS Nano; published by American Chemical Society 2015.
Effects of silver nanoparticle with different size and surface coatings in zebrafish.
| Life Stage | Shape | Size | Surface | Concentration and Time of Exposure | Mortality Value vs. Doses or LC50 | Results | Ref. |
|---|---|---|---|---|---|---|---|
| Embryos | Sphere | 5–35 nm | PVA | 10, 25, 50, 75, and 100 µg/mL, from 8-cell stage to 72 hpf | 43% at 100 µg/mL | Toxicity concentration dependent—increase in mortality rate—drop in hatching rate- different phenotypic defects (absence of eyes, growth retardation, undulated notochord, larvae shorter in length)—drop in the heartbeat—decrease of the touch response. | [ |
| Embryos | Sphere | 3, 10, 50, and 100 nm | No coatings or TPPMS | 50, 5, 0.5 and 0.05 mg/L, from 4 to 120 hpf | LC50: | High mortality rate, time and concentration dependent—not hatched embryos—problems in the circulatory system (i.e., blood clots and hemorrhages)—high incidence of malformations, most pronounced at 120 hpf (tail malformations, pericardial edema, bent spine, and small head). | [ |
| Embryos | Sphere | 2–20 nm | - | 1–3 µg/mL from 4 to 96 hpf | 45% at 3 µg/mL | 100% mortality at the highest concentration (3 µg/mL) tested—yolk sac edema and tail malformation at middle concentrations. | [ |
| Embryos | Sphere | 11 nm | Citrate | 0.04–0.06–0.07–0.08–0.19–0.38–0.57–0.66–0.71 nM, from 8-cell stage to 120 hpf | - | Toxicity concentration dependent—increase of the mortality—different types of malformations. | [ |
| Embryos | Sphere | 20 or 110 nm | Citrate (C) or PVP (P) | 0.8, 4, 20, 10, and 50 mg/L from 4 to 120 hpf | LC50: | Ag-NPs dissolved in UP and CaCl2 solutions more toxic than the one dissolved in EM—smaller NPs (20 nm) more toxic than larger (100 nm)—order of toxicity: 20 Ag-NPs-C > 20 Ag-NPs-P > 110 Ag-NPs-C ≈ 110 Ag-NPs-P. | [ |
| Embryos | Sphere | 5–20 nm | BSA | 5, 10, 25, 50 and 100 mg/L from 4 to 72 hpf | LC50: 5–50 μg /mL | Toxicity concentration dependent—increased mortality rate—hatching rate delay—severe malformations (pericardial edema, twisted notochord, abnormal body axes)—bradycardia. | [ |
| Embryos | Sphere | 10 nm | - | 3.9–8000 µg/L, from 4 to 48 hpf | No mortality | No mortality—at 24 and 48 hpf alteration in expression of genes associated with protein synthesis and oxidative phosphorylation (downregulation after 24 h of treatment and recovery after 48 h). | [ |
| Embryos | Sphere | 10–20 nm | DL-a-aminopropanoic acid | 5, 10, 25, 50 and 100 | 100% at 50–100 mg/L | Toxicity concentration dependent—100% mortality at the highest concentrations tested at 24 and 48 hpf—no alteration of heart beat rate—severe malformations (degeneration of the body, bent and twisted notochord, pericardial edema)—alteration in expression of relevant genes ( | [ |
| Embryos | Sphere | 42 nm | Citrate | 0.02–0.05–0.1–0.2 0.3–0.4–0.5 and 0.7 nM, from 4 to 120 hpf | - | Toxicity concentration dependent—100% of mortality at the high doses (≥ 0.2 nM)—different malformations (abnormal tail and spinal cord flexure, fin-fold deformities, eye/head defects, yolk sac edema, cardiac abnormalities) at low and middle doses (0.02–0.2 nM). | [ |
| Embryos | Sphere | 12 nm | Peptides: | 0.1, 0.2, 0.4, and 0.6 nM, from cleavage stage to 120 hpf | CALNNK+ζ 33% at 0.6 nM | Toxicity concentration and charge dependent—three Ag-peptide NPs caused several malformations (cardiac malformations, severe eye abnormalities, yolk sac edema, tail, and spinal cord flexure)—positively charged NPs (Ag-CALNNK NPs+ζ) less toxic—more negatively charged (Ag-CALNNE NPs−4ζ) most toxic. | [ |
| Embryos | Sphere | 4 and 10 nm | Oleic acid | 0.481, 0.963, 1.925, 3.850, 7.700, 11.550 and 23.100 mg/L, from 4 to 96 hpf | EC50: | Toxicity concentration dependent—severe malformations (bent notochord, yolk sac edema, eye, and head hypoplasia and disappearing somite)—decreased heartbeat rate, cardiotoxicity—smaller NPs (4 nm) more toxic than larger ones (10 nm)—at 24 hpf alteration in expression of neural genes ( | [ |
| Embryos | Sphere | 10 nm | Polyacrylate sodium | 0.03, 0.16, 0.31, 0.78, and 1.55 µg/mL of Ag, from 3 hpf to 5 dpf | LC5096 h: 1.18 µg/mL | Toxicity concentration dependent—increased mortality—hatching delay—reduced heartbeat rate at 48 hpf—high incidence of malformations (edema, bent tail, not depleted yolk and malformed spine)—increased ROS generation—depletion of GSH—no alteration in antioxidant enzymes activities. | [ |
| Embryos | Sphere | 20–30 nm | - | 20 ppt, from 2.5 to 72 hpf | Alteration in the expression of genes involved in apoptosis (54%) endocytosis (10%) and immune response (18%). | [ | |
| Embryos | Sphere | 20–40 nm | - | 0.03, 0.1, 0.3, 1 and 3 ppm, from 4 to 120 hpf | 5% at 3 ppm | No important changes in the mortality and hatching rates or percentage of malformations—perturbation in the behavior with hyperactivity. | [ |
| Embryos | Sphere | 1–20 nm | Liposomes | 100–0.001 mg/L, from 12 to 72 hpf | 100% at 100 mg/L | Toxicity concentration dependent—100% of mortality at the highest dose tested—scarce response to touch—decrease on the diameter of the eyes and body length—decrease of AChE and PChE activities—impaired recruitment of T-lymphocytes. | [ |
| Embryos | Sphere | 20 nm | Bare | 0.01, 0.1, 0.5, 1 and 10 mg/L, from 6 to 21 dpf (15 days) | - | Effect on survival rate—normal body length—perturbation in genes associated with photoreception and circadian clock regulation. | [ |
| Embryos | Sphere | sock-NPs: 37–165 nm spun-NPs: 15–50 nm | - | 0.01–0.83 mg/L, from 6 to 72 hpf | LC50 | 100% of mortality at the highest concentration tested by 24 h—reduced hatching rate and abnormal development at lower concentrations—perturbation in oxidative gene expression only for high doses (1.2 mg/L) of spun-NPs. | [ |
| Embryos | Sphere | 10 and 50 nm | Citrate (C) | 0.01–100 µM, from 6 hpf to 5 dpf | - | [ | |
| Embryos | Sphere | 120 nm | - | 0.01, 0.1, 1 and 5 mg/L, from 2/4 to 120 hpf | - | Hatching delay and morphological defects (curved backbones) at high concentrations—upregulation of ER stress markers ( | [ |
| Embryos | Sphere | 20–30 nm | - | 10 and 20 ppt, from 2.5 to 72 hpf | - | Toxicity concentration dependent—severe cardiac malformations at 72 hpf (blood pooling, pericardial edema)—abnormal notochord—apoptosis in the head—alteration of different gene expressions (activin, BMP, TGF-β, GSK3–β). | [ |
| Embryos | Sphere | 28 nm | Carbonate | 10–200 µM, from 2 to 6 hpf | LC50: | Toxicity dependent on the starting time of treatments and due to the Ag+ action—younger embryos more sensitive. | [ |
| Embryos | Sphere | 46/110 nm | PVP | 0.001–100 ppm, from 4 to 72 hpf | LC5048 h | Order of toxicity PVP > Thiol > TSC > BIO—most significant perturbations in the heart rate of embryos treated with | [ |
| Embryos and adults | Sphere | 20–30 nm | Sodium citrate | 0–10 mg/L, 48 h | LC5048 h | LC5048h less than 10 mg/L in both embryos and adult organisms. | [ |
| Embryos/Adults | Sphere | 5 nm | PVP/PEI | Embryos: 10 μg/L–10 mg/L for 5 days | LC50120 h: 50 μg/L | [ | |
| Embryos | Sphere | 25–75 nm | PVP | 0–100 mg/L, from 24 to 120 hpf | LC5024–48 hpf: 51 mg/L | Toxicity increase during the development—less sensitivity compared to AgNO3—alteration in expression of metal ion chaperone metallothionein. | [ |
| Embryos | Sphere | 20–40 nm | - | 10 and 500 µg/mL, from 3/3.5 to 72 hpf | Ec-Ag-NP: 154 µg/mL | Toxicity dependent on concentration biogenicity and exposure time—hatching delay—decreased heartbeat rate—malformations (yolk, notochord, gastrointestinal lumen)—apoptosis in the tail area and head—ROS production. | [ |
| Embryos | Sphere | 4 and 10 nm | Oleic acid | 0.481, 0.963 and 1.925 mg/L, from 4 to 96 hpf | - | [ | |
| Embryos | Sphere | 9 and 30 nm | PVP and EG | 10 and 20 µg/mL from 4 to 120 hpf | 9 nm: 100% at 20 µg/mL | Toxicity size and concentration dependent—increased mortality rate—decreased hatching rate and heartbeat rates—high incidence of malformations (tail malformation, yolk sac edema, axial deformity, pericardial edema, eye defects). | [ |
| Embryos | Sphere | 12 and 49 nm | PVP | 2 mg/L Ag | PVP-Ag-NPs in WP: 8% | Mortality rates of zebrafish treated with of GA-Ag-NPs or PVP-Ag-NPs in three different matrices lower with respect to GA-Ag-NPs or PVP-Ag-NPs in water-sediments protective against the | [ |
| Embryos | Sphere | 10 and 35 nm | Bare | 5, 50, 500, 5000, and 25.000 µg/L, from 1.5 to 48 hpf | 10 nm | Toxicity size and concentration dependent—35 nm Ag-NPs more toxic than 10 nm—coated NPs less toxic than the uncoated ones. | [ |
| Embryos | Sphere | 15, 35, and 80 nm | Bare | 0.05–1000 µM, from 4 to 96 hpf | EC50: | Decreasing toxicity order: DIS-nAg > PVP-nAg > Bare-nAg. | [ |
| Embryos | Sphere | 40 nm | Citrate | 0.4 mg/L, from 4 to 72 hpf | - | Hypopigmentation—reduced xanthocytes and melanocytes—alteration in expression of xanthophone ( | [ |
| Embryos | Sphere | 10 and 40 nm | Citrate | 0.2, 0.4, 0.75 and 1 mg/L, from 4 to 96 hpf | - | [ | |
| Adults | Sphere | < 30 nm | 15.5, 18.6, 21.7, 24.8, 27.9 and 31 μg/L for 96 h | LC5096 h: 24.5 μg/L | Toxicity concentration dependent—100% mortality at the highest concentration tested after 12 h—aggressive behavior after 6 h—cytological changes in gills and liver (pyknotic nuclei, cell membrane damage)—high levels of AST and ALT—production of ROS—alteration in expression of genes associated with immune response (C/EBP, IL1β and LYZ, MPO, TLR22, NF-κB, and TLR4) and oxidative stress (MTF1, HSP70). | [ | |
| Adults | Sphere | 5–20 nm | - | 30, 60 and 120 mg/mL, 24 h | - | Cellular disruption in the liver tissue (pyknosis and chromatin condensation)—increase of MDA and GHS levels—alteration in the expression of oxyradical scavenging enzymes (Cat and GPx1 a)—DNA damage—upregulation of proapoptotic genes ( | [ |
| Adults | Sphere | 81 nm | PVP | 18, 36, 54, 72, 89, 107, 125, and 143 μg/L, 48 h | LC5048 h: 84 μg/L | Toxicity concentration dependent—100% mortality after 24 h exposure to the highest concentration tested (143 μg/L)—extravasations of blood in the anterior ventral surface of the body—lost equilibrium—increased respiratory rate. | [ |
| Adults | Sphere and polygon | 11–45 nm17–40 nm | - | for 28 days | LD5096 h: | Biologically synthetized Ag-NPs less toxic in comparison to both the chemical counterparts and Ag NO3—histological damage in ovarian tissue (mild atresia). | [ |
| Adults | Sphere | 22–26 nm | PVP | 0.1 ppm, 15 days | - | Sulfidation mitigated the toxicity—mitigation of induced oxidative stress—protection of liver and brain biochemical enzymes. | [ |
| Adults | Sphere | 20–30 nm | - | 1 mg/L, 24 h and 48 h | - | No alteration in gill filament—dramatic alterations in global gene expression patterns, particularly genes associated with mitogenesis, proliferation, and apoptosis. | [ |
| Adults | Sphere | 3 nm | Citrate | 5, 15, 25, or 50 µg/L, 28 days | No mortality | No mortality—no morphological alterations in gills—significant alterations in the expression of genes associated with morphogenesis and developmental processes. | [ |
| Adults | Sphere | 25 nm | - | 8, 45, and 70μg/L for 30 days | - | Damage in gills structure (lamellar fusion, subepithelial edema)—necrosis of intestinal villi—high expression of MTs1. | [ |
| Adults | Sphere | 25–100 nm | Bare | 5, 10, 20, 25, and 30 mg/L for 4 days—2 and 4 mg/L for 1–3 weeks | LC5096 h: 16.76 mg/L | Mortality concentration and time dependent—decrease of gill Na+/K+ ATPase activity only after 14 and 21 days—decreased erythrocyte AChE activity after 4 d—alterations of electrolyte levels in a short time—increase of plasma cortisol and glucose levels. | [ |
| Adults | Sphere | 5–50 nm | - | 23.7, 47.4, 142.2, 237, 284.4, 331.8 µg/L, for 96 h | LC5096 h: 142.2 µg/L | [ | |
| Adults | Sphere | 50.7 ± 1.8 nm | - | 10, 33 or 100 μg/L for 35 days | - | Alteration of gut microbiota composition in terms of richness and diversity only in male fish—Male: abundance of | [ |
| Adults | Sphere | 20–70 nm | - | 10, 33, and 100 mg/L for 5 weeks | No mortality | No mortality—both in testis and ovary ROS generation—decrease of fecundity—increase of apoptotic cells in gonads—alteration in the expression of genes linked to mitochondrion-mediated apoptosis ( | [ |
| Adults | Sphere | 10 | PVP | 1 or 5 mg/kg by injection for 24 h | No mortality | No mortality—damage in kidneys, spleen, heart, and gall bladder—alteration in the expression of IL-1 and TNFα, caspase 6 and 9. | [ |
| Adults | Sphere | 20–110 nm | Citrate | 1 ppm, for 4 h, 4 days, or 4 days plus 7 days | - | Size-dependent toxicity—morphological changes in intestines and gills—decrease of Na+/K+ ATPase activity. | [ |
Abbreviations: AchE: acetylcholine esterase; AST: aspartate transaminase; ALT: aka alanine aminotransferase; BIO: biocompatible gelatin; BSA: bovine serum albumin; Cat: catalase; C/EBP: CCAAT-enhancer binding protein; DIS: dispersant; dpf: days post fertilization; EG: Ethylene glycol; EM: embryo medium; ER: endoplasmatic reticulum; GA: gum arabic; GPx1 a: glutathione peroxidase 1 a; GSH: glutathione; HIF4: hypoxia inducible factor 4; HSP70: heat-shock protein 70; hpf: hours post fertilization; IL1: interleukin 1; IL1β: interleukin 1 beta; LC50: lethal concentration, 50%; LYZ: lysozyme; MDA: Malondialdehyde; MTs: metallothioneins; MT1 s: metallothioneins 1; MTF1: metal transcription factor 1; NF-κB: nuclear factor-κB; PChE: pseudocholinesterase; PEI: polyethylenimine; PVA: polyvinyl alcohol; PVP: polyvinylpyrrolidone; Pxmp2: perosomial membrane protein 2; ROS: reactive oxygen species; Thiol: 16-Mercaptohexacanoic Acid; TPPMS: triphenylphosphine monosulfonate; TLR22: Tolllike receptor 22; TNFα: Tumor necrosis factor 1; TSC: Trisodium citrate; UP: ultrapure water; W: water only; WP: water + plants; WPS: water + plants + sediment; WS: water +sediment.